ArticleCancer immunology research2024

An IRF2-Expressing Oncolytic Virus Changes the Susceptibility of Tumor Cells to Antitumor T Cells and Promotes Tumor Clearance.

Lulu Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.